profit from every ₹100 of sales.
₹0₹100
Jubilant Ingrevia
₹592.35-1.26% today
-16.0% in 1 year
1-year low ₹541.701-year high ₹764.25
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹33.63 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Jubilant Ingrevia sold, what it kept, and what it did with the cash.
Sales went from ₹47.4 billion in 2023 to ₹43.4 billion in 2026, with ₹2.78 billion of profit last year.
SalesProfit
Jubilant Ingrevia handed back 50% of the cash it generated last year.
₹793M
Free cash flow 2026₹2.2B
Bought back its own shares₹322M
Paid as dividends₹793M
Cash vs. debt₹1.9B vs. ₹7.9B
Jubilant Ingrevia vs. similar companies
Jubilant Ingrevia grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Jubilant Ingrevia | 33.6× · Expensive | ||
 Linde | 35.0× · Expensive | ||
 L'Air Liquide | 35.1× · Expensive | ||
 Ecolab | 41.8× · Expensive | ||
 The Sherwin-Williams | 32.9× · Expensive |
AI analysis
An AI analyst reads Jubilant Ingrevia's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 47,405 | 41,004 | 41,237 | 43,449 | |
| 20,441 | 18,505 | 20,164 | 20,501 | |
| 4,441 | 2,940 | 3,615 | 3,916 | |
| 5,793 | 4,558 | 5,569 | 5,944 | |
| 3,075 | 1,829 | 2,512 | 2,779 | |
| 19.33 | 11.55 | 15.84 | – | |
| 43.1% | 45.1% | 48.9% | 47.2% | |
| 9.4% | 7.2% | 8.8% | 9.0% | |
| 6.5% | 4.5% | 6.1% | 6.4% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 42,589 | 47,319 | 50,318 | 54,837 |
| Cash | 727 | 788 | 694 | 1,885 |
| Total debt | 4,067 | 7,402 | 7,638 | 7,918 |
| Total liabilities | 15,926 | 19,944 | 21,047 | 23,575 |
| 26,662 | 27,375 | 29,271 | 31,262 | |
| 159 | 158 | 159 | – | |
| 11.8% | 7.3% | 8.5% | 8.4% | |
| 11.5% | 6.7% | 8.6% | 8.9% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 4,625 | 4,300 | 5,081 | 5,243 | |
| 4,814 | 5,684 | 3,658 | 2,994 | |
| -189 | -1,384 | 1,423 | 2,249 | |
| Dividends paid | 793 | 786 | 798 | 793 |
| 0 | 429 | 0 | 322 | |
| 27 | 67 | 121 | 107 |
Valuation
- 33.6×
- –
- –
- 3.1×
- 2.2×
- 41.5×
- 16.7×
- 2.4%
- 3.0%
- 0.8%
Profitability
- 47.2%
- 9.0%
- 6.4%
- –
- 8.0%
- 8.5%
- –
- –
- –
- –
Growth
- −2.9%
- –
- –
- –
- −0.1%
Financial health
- 1.0×
- 0.25
- –
- 8.5×
- 1.29
- –
- –
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 40%of 989
Bottom 46%of 954
Bottom 28%of 778
Bottom 28%of 940
Top 48%of 990
0.8%of the share price, paid each year
On $1,000 invested$8a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
28.5% of its profit
Room to growStretchedMore than it earns: 35.2%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
41No pass
Benjamin Graham
40No pass
Philip Fisher
42No pass
Peter Lynch
39No pass
Joel Greenblatt
17No pass
Charlie Munger
35No pass
Terry Smith
27No pass
Questions about Jubilant Ingrevia
Is Jubilant Ingrevia a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Jubilant Ingrevia AI analysis
What does Jubilant Ingrevia do?
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. It is in Specialty Chemicals, based in Noida, India.
Does Jubilant Ingrevia pay a dividend?
Yes. At today's price the dividend is 0.8% a year, about 29% of its yearly profit. In 2026 it paid out ₹793 million in dividends.
Is Jubilant Ingrevia stock halal?
Yes. Jubilant Ingrevia passes our halal screen: its business is permitted and its debt is 8% of its market value, under the 30% limit. How we check
How has Jubilant Ingrevia stock done over the past year?
Down 16.0% over the past twelve months, to ₹592.35. It traded between ₹541.70 and ₹764.25 and is 22.5% below its high.
Who are Jubilant Ingrevia's competitors?
The largest listed companies in the same industry are Linde, L'Air Liquide, Ecolab and The Sherwin-Williams. The peers table on this page compares their profit, growth and price with Jubilant Ingrevia's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.